Microvast stock falls after Grizzly report alleges fabricated business

Microvast Holdings Inc. (NASDAQ:MVST) stock fell 7% following a scathing report from short-seller Grizzly Research, which alleges the battery company is fabricating significant aspects of its business and capabilities. The report, "Microvast’s House of Lies," cites extensive on-site observations indicating minimal activity at its German facility, significantly fewer employees at its main China plant than disclosed, failed U.S. business initiatives, and problematic ties to the Chinese government that led to a denied $200 million grant. Grizzly also claims over 95% of Microvast's non-China partnerships are insignificant, while documentation proves Chinese government shareholding in its main subsidiary, allegations to which Microvast has not yet responded.

Analysis

Microvast Holdings (MVST) experienced a significant 7% stock price decline following the release of a highly critical report by short-seller Grizzly Research. The report alleges severe misrepresentation of the company's operational scale and financial health, directly challenging its core investment thesis. Grizzly Research claims its on-site investigations revealed minimal production activity at Microvast's German facility, which it contrasts with company guidance of up to 250 employees. Furthermore, the report alleges a substantial discrepancy in headcount at the primary Chinese facility, citing approximately 1,400 employees versus the 2,500 disclosed by the company. The allegations extend to Microvast's U.S. operations, which are described as failures, highlighted by the denial of a $200 million government grant due to suspected ties to the Chinese government—a major geopolitical and funding risk. The report also undermines the quality of Microvast's revenue streams, asserting that over 95% of its partnerships outside of China are with nascent startups offering insignificant economic value. Compounding these issues are claims of direct, undisclosed shareholding by the Chinese government in a key subsidiary, a critical governance concern. As of the report, Microvast, which went public via a SPAC in 2021, has not issued a response, leaving these serious allegations unanswered and creating significant uncertainty for investors.

Key Decisions for Investors

• Given the severity of the allegations regarding operational capacity and undisclosed government ties, investors should treat the stock with extreme caution and closely monitor for an official company rebuttal addressing each specific claim from the Grizzly Research report.
• The denial of the $200 million U.S. government grant and accusations of insignificant partnerships materially alter the company's growth outlook and risk profile, warranting a complete reassessment of any existing investment thesis.
• The stock faces heightened downside risk and volatility until there is clarity; current holders may consider reviewing position sizing or implementing risk management strategies, while prospective investors should await a formal company response and independent verification before committing capital.